Arginase-1 and Treg Profile Appear to Modulate Inflammatory Process in Patients with Chronic Gastritis: IL-33 May Be the Alarm Cytokine in H. pylori-Positive Patients

Table 1

Comparison of clinical data with the presence of H. pylori studied in the gastric antrum through the PAD ().

Clinical data	Number	H. pylori +	H. pylori -
Male	42 (33.3%)	14 (11.1%)	28 (22.2%)
Women	84 (66.7%)	28 (22.2%)	56 (44.4%)
Epigastric pain	105 (83.3%)	35 (27.8%)	70 (55.6%)
Nausea	56 (44.4%)	21 (16.7%)	35 (27.8%)
Pirose	86 (68.3%)	27 (21.4%)	59 (46.8%)
Dysphagia	30 (23.8%)	15 (11.9%)	15 (11.9%)
Regurgitation	42 (33.3%)	17 (13.5%)	25 (19.9%)
Smoking	22 (17.5%)	6 (4.8%)	16 (12.7%)
Ethicism	50 (39.7%)	20 (15.9%)	30 (23.8%)
Obesity	27 (21.4%)	13 (10.3%)	14 (11.1%)
Diabetes	12 (9.5%)	5 (4.0%)	7 (5.6%)
Previous treatment GERD	48 (38.1%)	16 (12.7%)	32 (25.4%)
Previous treatment of gastritis	37 (29.4%)	8 (6.3%)	29 (23.0%)
Previous treatment H. pylori	19 (15.1%)	3 (2.4%)	16 (12.7%)

.